AN OPEN-LABEL INTERNATIONAL PHASE III STUDY OF THE LONG-TERM SAFETY OF LIPROTAMASE FOR TREATMENT OF PANCREATIC INSUFFICIENCY IN CF

被引：0
|
作者：
Borowitz, D. [1 ]
Stevens, C. [2 ]
Fratazzi, C. [2 ]
Cohen, D. [2 ]
Campion, M. [2 ]
机构：
[1] SUNY Buffalo, Womens & Childrens Hosp, Dept Pediat, Buffalo, NY 14260 USA
[2] Alnara Pharmaceut Inc, Cambridge, MA USA
来源：
PEDIATRIC PULMONOLOGY | 2009年
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
520
引用
收藏
页码：397 / 398
页数：2
相关论文
共 50 条
  • [1] Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia
    Chambers, Mark S.
    Jones, Christopher Uwe
    Biel, Merrill A.
    Weber, Randal S.
    Hodge, Kenneth M.
    Chen, Y.
    Holland, John M.
    Ship, Jonathan A.
    Vitti, Robert
    Armstrong, Ingrid
    Garden, Adam S.
    Haddad, Robert
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (05): : 1369 - 1376
  • [2] A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
    Camporeale, Angelo
    Kudrow, David
    Sides, Ryan
    Wang, Shufang
    Van Dycke, Annelies
    Selzler, Katherine J.
    Stauffer, Virginia L.
    BMC NEUROLOGY, 2018, 18
  • [3] A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
    Angelo Camporeale
    David Kudrow
    Ryan Sides
    Shufang Wang
    Annelies Van Dycke
    Katherine J. Selzler
    Virginia L. Stauffer
    BMC Neurology, 18
  • [4] Long-term safety of deutetrabenazine for the treatment of tardive dyskinesia: Results from an open-label, long-term study
    Anderson, K.
    Stamler, D.
    Davis, M.
    Factor, S.
    Hauser, R.
    Isojarvi, J.
    Jarskog, L.
    Jimenez-Shahed, J.
    Kumar, R.
    Ochudlo, S.
    Ondo, W.
    Fernandez, H.
    MOVEMENT DISORDERS, 2017, 32
  • [5] Long-Term Open-Label Safety Study of Rizatriptan Acute Treatment in Pediatric Migraineurs
    Hewitt, David J.
    Pearlman, Eric
    Hamalainen, Mirja
    Lewis, Donald
    Connor, Kathryn M.
    Michelson, David
    Ceesay, Paulette
    Assaid, Christopher
    Bachman, Robert
    Mozley, Lyn Harper
    Dupre, Nicole
    Strickler, Nancy
    Mahoney, Erin
    Lines, Christopher
    Ho, Tony W.
    HEADACHE, 2013, 53 (01): : 104 - 117
  • [6] A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine
    Croop, Robert
    Berman, Gary
    Kudrow, David
    Mullin, Kathleen
    Thiry, Alexandra
    Lovegren, Meghan
    L'Italien, Gilbert
    Lipton, Richard B.
    CEPHALALGIA, 2024, 44 (04)
  • [7] Safety of long-term use of linezolid: results of an open-label study
    Vazquez, Jose A.
    Arnold, Anthony C.
    Swanson, Robert N.
    Biswas, Pinaki
    Bassetti, Matteo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1347 - 1354
  • [8] Long-term, open-label, phase III multicenter study of tamsulosin in benign prostatic hyperplasia
    Narayan, P
    Lepor, H
    UROLOGY, 2001, 57 (03) : 466 - 470
  • [9] Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia
    Kasper, S
    Brecher, M
    Fitton, L
    Jones, AM
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (05) : 281 - 289
  • [10] Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD)
    Boada, Merce
    Neve, Anuja
    Das, Bibha
    Wojtowicz, Jakub
    Huang, Zhiyue
    Bullain, Szofia
    Watkin, Michelle
    Lott, Dominik
    Bittner, Tobias
    Delmar, Paul
    Klein, Gregory
    Hofmann, Carsten
    Kerchner, Geoffrey A.
    Smith, Janice
    Baudler, Monika
    Fontoura, Paulo
    Doody, Rachelle S.
    JOURNAL OF ALZHEIMERS DISEASE, 2025, 103 (02) : 528 - 541
12345